Latest Videos |view all videos
Bernard J. Gersh, M.B., Ch.B., D.Phil., and Charles J. Bruce, M.D., discuss cardiovascular physiological monitoring, including a recent FDA-approved device and the technology's positive impact on health care.
Bernard Gersh, M.B., Ch.B., D.Phil., and Lori Blauwet, M.D., discuss peripartum cardiomyopathy and Dr. Blauwet's research into its prevalence among African women.
Patricia A. Pellikka, M.D., director of Mayo Clinic's Echocardiography Laboratory, and Stephen Kopecky, M.D., Mayo Clinic cardiologist, discuss medical therapies for the treatment of stable coronary artery disease.
Douglas L. Packer, M.D., and Michael J. Ackerman, M.D., Ph.D., discuss long QT syndrome, the consequences of guideline-based recommendations for disqualification and the JAMA article discussing sports guidelines for long QT syndrome patients.
Rajiv Gulati, M.D., Ph.D., and John M. Stulak, M.D., discuss the advancement of VADs and their role as a destination therapy in treating people with advanced heart failure.
Michael J. Ackerman, M.D., Ph.D., discusses the relationship between victims of an otherwise-unexplained drowning and a collection of genetic heart rhythm disorders known as the cardiac channelopathies.
Dr. Charanjit (Chet) Rihal, Chair of the Division of Cardiovascular Diseases at Mayo Clinic in Rochester, MN, discusses the Proceedings on the state of the art technique and outcomes with the use of endomyocardial biopsy.
Dr. Juan N. Pulido interprets the results of a study described in the July 2012 issue of Mayo Clinic Proceedings, frequency and significance of myocardial dysfunction in patients with severe sepsis and septic shock using transthoracic echocardiography.
Dr. Amir Lerman discusses his article appearing in the October 2012 issue of Mayo Clinic Proceedings where he reports on a cluster of risk factors that have a greater impact on disease progression.